Cellular binding partners of the human papillomavirus E6 protein

被引:0
|
作者
Sandy S. Tungteakkhun
Penelope J. Duerksen-Hughes
机构
[1] Loma Linda University School of Medicine,Department of Basic Sciences
来源
Archives of Virology | 2008年 / 153卷
关键词
Paxillin; Death Effector Domain; Long Control Region; Epithelial Tight Junction; Epithelial Organization;
D O I
暂无
中图分类号
学科分类号
摘要
The high-risk strains of human papillomavirus (HR-HPV) are known to be causative agents of cervical cancer and have recently also been implicated in cancers of the oropharynx. E6 is a potent oncogene of HR-HPVs, and its role in the progression to malignancy has been and continues to be explored. E6 is known to interact with and subsequently inactivate numerous cellular proteins pivotal in the mediation of apoptosis, transcription of tumor suppressor genes, maintenance of epithelial organization, and control of cell proliferation. Binding of E6 to these proteins cumulatively contributes to the oncogenic potential of HPV. This paper provides an overview of these cellular protein partners of HR-E6, the motifs known to mediate oncoprotein binding, and the agents that have the potential to interfere with E6 expression and activity and thus prevent the subsequent progression to oncogenesis.
引用
收藏
相关论文
共 50 条
  • [41] Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein
    Brimer, Nicole
    Lyons, Charles
    Pol, Scott B. Vande
    VIROLOGY, 2007, 358 (02) : 303 - 310
  • [42] The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
    Tomaic, Vjekoslav
    Pim, David
    Banks, Lawrence
    VIROLOGY, 2009, 393 (01) : 7 - 10
  • [43] The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP
    Elston, RC
    Napthine, S
    Doorbar, J
    JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 371 - 374
  • [44] THE ROLE OF HUMAN PAPILLOMAVIRUS-52 E6 IN CARCINOGENESIS
    Chan, P.
    Lai, L.
    Boon, S.
    Law, P.
    Thomas, M.
    Banks, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 720 - 720
  • [45] Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6
    Lagrange, M
    Charbonnier, S
    Orfanoudakis, G
    Robinson, P
    Zanier, K
    Masson, M
    Lutz, Y
    Trave, G
    Weiss, E
    Deryckere, FO
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1001 - 1007
  • [46] The Human Papillomavirus (HPV) E6*Proteins from High-Risk, Mucosal HPVs Can Direct Degradation of Cellular Proteins in the Absence of Full-Length E6 Protein
    Pim, David
    Tomaic, Vjekoslav
    Banks, Lawrence
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 9863 - 9874
  • [47] The E6 oncoprotein of human papillomavirus 16 as a therapeutic target
    Dymalla, Susanne
    Butz, Karin
    Lohrey, Claudia
    Scheffner, Martin
    Sehr, Peter
    Lewis, Joe
    Hoppe-Seyler, Felix
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3606S - 3606S
  • [48] PKN binds and phosphorylates human papillomavirus E6 oncoprotein
    Gao, QS
    Kumar, A
    Srinivasan, S
    Singh, L
    Mukai, H
    Ono, Y
    Wazer, DE
    Band, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 14824 - 14830
  • [49] Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization
    Strickland, Sydney Webb
    Brimer, Nicole
    Lyons, Charles
    Vande Pol, Scott B.
    VIROLOGY, 2018, 516 : 127 - 138
  • [50] HUMAN PAPILLOMAVIRUS E6 TRANSFORMING PROTEIN ABROGATES P53 TRANSCRIPTIONAL ACTIVITY
    SINHA, J
    ANDROPHY, E
    MANSUR, CP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 500 - 500